The most common drugs used in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) treatment include dasatinib. Although Dasatinib has been shown to have high levels of effectiveness there are patients and caregivers who have expressed concern about the cost implications of the medication. It is, therefore, crucial for the patient to have a clue on some of the factors... https://www.nasseej.net/blogs/179998/Understanding-Dasatinib-What-Factors-Affect-Its-Price